We transform medical images into meaningful, actionable insights to help better diagnose, treat, and monitor patients. We deploy proprietary artificial intelligence, computer vision, and signal processing technologies to develop imaging tests and services, addressing life-threatening unmet medical needs.
iCRO
eyonis™
Median’s Imaging CRO business provides leading oncology clinical trial imaging services, empowering our life sciences partners to accelerate the development and delivery of life-saving cancer treatments with unmatched operational excellence and reliability. And we don’t stop there. We are forging the way when it comes to innovative imaging technology, leveraging the latest in AI-powered imaging intelligence to develop actionable insights for biopharma sponsors worldwide.
With eyonis™ we are disrupting the management of serious diseases such as lung cancer and liver cancer. We are deploying AI/ML Software as Medical Devices (SaMDs) to help health professionals diagnose patients earlier, treat them more effectively, and bring new hope. eyonis™ is currently under development.
eyonis
Insights Median In The Media
请输入验证码
我同意接收有关影研医疗科技的网络研讨会及服务信息。
影研医疗科技仅收集能支持我们有效处理您的查询所需的最少相关信息。如您需了解更多关于我们如何存储和处理您个人数据以及您的相关权利，请参阅我们的 个人数据保护政策。
